FindTrial
Sign In

Safety of the peripheral administration of norepinephrine in the postoperative intensive care patients

Safety of the peripheral administration of norepinephrine in the postoperative intensive care patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040272
Enrollment
Unknown
Registered
2020-11-27
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative hypotention

Interventions

Case series:peripheral administration of norepinephrine

Sponsors

Union hospital Tongji medical college Huazhong university of science and technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. At least 18 years of age; 2. PVL-pumped norepinephrine in patients transferred to intensive care postoperatively.

Exclusion criteria

Exclusion criteria: 1. Norepinephrine is not used; 2. With CVC or PICC when transferring; 3. Pump norepinephrine along with other vasoactive drugs; 4. The duration of norepinephrine use is less than 1 hour.

Design outcomes

Primary

MeasureTime frame
time of administration of norepinephrine;peripheral vessel leakage;—

Contacts

Public ContactYUYUAN

Union hospital Tongji medical college Huazhong university of science and technology

271326264@qq.com+86 13971256590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026